<p>(A) Western blot was used to determine the cFLIP<sub>L</sub> protein level after transfection with cFLIP<sub>L</sub> siRNA for 24 h. (B-C) Transfected cells were treated with TRAIL in the presence or absence of shDcR3 for 24 h. IETDase colorimetric assay was used to determine the IETDase and DEVDase activities in cell lysates. (D) Western blot was used to detect the mitochondrial cytochrome c release. (E) CCK-8 assay was used to determine the cell viability. (F) Cells were transfected with mock or cFLIP<sub>L</sub> vector for 24 h, cFLIP<sub>L</sub> protein level was detected by western blot. In the presence or absence of shDcR3, transfected cells were treated with TRAIL for 4 h. CCK-8 was used to measure the cell viability. Each value r...
<p><b>(A)</b> The inhibition of cell viability after CsA treatment. After adding 5 μg/ml CsA for 72 ...
Cytotoxic lymphocytes kill tumor or virus-infected target cells utilizing two mechanisms (1) release...
<p>The indicated transfectants were treated without and with 50 nM LBH589 plus 25 ng/ml TRAIL (L/T) ...
<p>When RD-A cells infected with EV71 or without EV71 were co-cultured with different dosage of Z-VA...
<p><b>(A)</b> In the presence or absence of shDcR3 and z-VAD, HepG2 cells were treated with TRAIL (7...
<p>(<b>A</b>) Expression of cFLIP isoforms (long and short) and methyltransferase EZH2 in different ...
<p>Stable ER-E2F1 PC12 cells were transfected or not with Bcl-xL (A) or cFLIP (B) expression plasmid...
<p>In the presence or absence of shDcR3 and z-VAD, Huh7 cells were treated with TRAIL (75ng/ml) for ...
<p>(A) MCF7 cells were mock-treated, or transfected with two different siRNAs targeting HSP27 (siRNA...
<p>(<b>a</b>) In normal-glucose condition, over-express of cFLIP promotes proliferation and Fibronec...
<p>(A) Cell viability examined by trypan blue exclusion in LNCaP (LN), LNb4 and PC-3 cells. (B) Dete...
<p>(A) ACHN cells were treated for 4 h with 1 μM of the indicated compound at which point cells were...
The protein cFLIP is suspected to protect cells against programmed cell death (apoptosis) in cervica...
The protein cFLIP is suspected to protect cells against programmed cell death (apoptosis) in cervica...
<p>(A) MCF7 and MCF10A cells were transfected for 24 hours with vectors encoding FLAG-tag fusions of...
<p><b>(A)</b> The inhibition of cell viability after CsA treatment. After adding 5 μg/ml CsA for 72 ...
Cytotoxic lymphocytes kill tumor or virus-infected target cells utilizing two mechanisms (1) release...
<p>The indicated transfectants were treated without and with 50 nM LBH589 plus 25 ng/ml TRAIL (L/T) ...
<p>When RD-A cells infected with EV71 or without EV71 were co-cultured with different dosage of Z-VA...
<p><b>(A)</b> In the presence or absence of shDcR3 and z-VAD, HepG2 cells were treated with TRAIL (7...
<p>(<b>A</b>) Expression of cFLIP isoforms (long and short) and methyltransferase EZH2 in different ...
<p>Stable ER-E2F1 PC12 cells were transfected or not with Bcl-xL (A) or cFLIP (B) expression plasmid...
<p>In the presence or absence of shDcR3 and z-VAD, Huh7 cells were treated with TRAIL (75ng/ml) for ...
<p>(A) MCF7 cells were mock-treated, or transfected with two different siRNAs targeting HSP27 (siRNA...
<p>(<b>a</b>) In normal-glucose condition, over-express of cFLIP promotes proliferation and Fibronec...
<p>(A) Cell viability examined by trypan blue exclusion in LNCaP (LN), LNb4 and PC-3 cells. (B) Dete...
<p>(A) ACHN cells were treated for 4 h with 1 μM of the indicated compound at which point cells were...
The protein cFLIP is suspected to protect cells against programmed cell death (apoptosis) in cervica...
The protein cFLIP is suspected to protect cells against programmed cell death (apoptosis) in cervica...
<p>(A) MCF7 and MCF10A cells were transfected for 24 hours with vectors encoding FLAG-tag fusions of...
<p><b>(A)</b> The inhibition of cell viability after CsA treatment. After adding 5 μg/ml CsA for 72 ...
Cytotoxic lymphocytes kill tumor or virus-infected target cells utilizing two mechanisms (1) release...
<p>The indicated transfectants were treated without and with 50 nM LBH589 plus 25 ng/ml TRAIL (L/T) ...